InvestorsHub Logo
Followers 9
Posts 3462
Boards Moderated 0
Alias Born 06/30/2021

Re: Mojocash post# 17840

Monday, 05/27/2024 9:53:31 PM

Monday, May 27, 2024 9:53:31 PM

Post# of 25591
Giving proof of what? Fool. You can show them what and they still won believe what now? You/him and the rest are just too dumb because you don't even know what that report said.

Because none of you read it . You all are all Stoopids. So are you going to believe what you are shown as proof now?


However, our study confirms findings of previously identified rare cases of myocarditis and pericarditis following first and second doses of mRNA vaccines


Another potential safety signal was identified for ADEM after the first dose of mRNA-1273 vaccine, with five more observed than expected events based on 1,035,871 person-years and 10.5 million doses administered; however, the number of cases of this rare event were small and the confidence interval wide, so results should be interpreted with caution and confirmed in future studies.

Although some case reports have suggested a possible association between COVID-19 vaccination and ADEM, there was no consistent pattern in terms of vaccine or timing following vaccination, and larger epidemiological studies have not confirmed any potential association [41], [42], [43]

Frontera et al. [46] concluded that chances of having a neurological event following acute SARS-CoV-2 infection were up to 617-fold higher than following COVID vaccination, suggesting that the benefits of vaccination substantially outweigh the risks.

Aggregating data from multiple countries on more than 99 million vaccine recipients has significantly increased the sample size and the statistical power compared with many previous safety studies. This enhances the ability to detect safety signals, especially for extremely rare adverse events, as the larger sample size provides greater precision in estimating observed rates.
Moreover, overall risk–benefit evaluations of vaccination should take the risk associated with infection into account, as multiple studies demonstrated higher risk of developing the events under study, such as GBS, myocarditis, or ADEM, following SARS-CoV-2 infection than vaccination.

While our study confirmed previously identified rare safety signals following COVID-19 vaccination
and contributed evidence on several other important outcomes, further investigation is warranted to confirm associations and assess clinical significance.




This study identified two new, but very rare, side effects associated with covid-19 vaccines. Boo hoo .

All vaccines have side effects.

It also confirmed previously identified rare safety signals for myocarditis and pericarditis after a mRNA vaccine (Pfizer and Moderna) and Guillain-Barré syndrome and cerebral venous sinus thrombosis (CVST) after viral vector vaccines (AstraZeneca).

The report like all others say the benefits of the vaccine outweigh the risks of the very rare side effects.

Do you Maga idiot not get vaccinated for other diseases like the measles?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.